Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Receptos LLC has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This single matter is assigned to 1 distinct examiner and is located within 1 distinct art unit. The company's current prosecution activity is highly focused on a specific pharmaceutical or biotechnological innovation.
MERTZ, PREMA MARIA is the busiest examiner for Receptos LLC, handling 1 pending office action. As the only 1 distinct examiner listed for the company, this individual manages the entire pending portfolio. This centralization allows for a very direct and consistent line of communication between the examiner and the company's legal team regarding the 1 pending office action.
The 1 distinct art unit involved confirms that the technology is concentrated in a specific regulatory path. With only 1 pending office action, the current administrative requirements for the company's patent portfolio are minimal. This profile reflects a very targeted and specialized approach to intellectual property in the Biotechnology & Pharmaceuticals sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MERTZ, PREMA MARIA | 1 | 71.7% | +35.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18597286 | METHODS OF TREATING ATOPIC DERMATITIS | MERTZ, PREMA MARIA | — |
| Art Unit | Apps |
|---|---|
| 1646 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18597286 | METHODS OF TREATING ATOPIC DERMATITIS | MERTZ, PREMA MARIA | 1646 | DP | Non-Final OA | — | Pending | Mar 06, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial